Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Jun 01, 2017 12:39 pm UTC| Business
BERKELEY, Calif., June 01, 2017 -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, announced today that the U.S. Food and Drug Administration (FDA) has...
Catalyst Pharmaceuticals to Present at the Jefferies 2017 Healthcare Conference
Jun 01, 2017 12:37 pm UTC| Business
CORAL GABLES, Fla., June 01, 2017 -- Catalyst Pharmaceuticals, Inc.(Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...